[
    [
        {
            "time": "",
            "orginal_text": "【建投中小盘】一周策略回顾与展望",
            "features": {
                "keywords": [
                    "建投",
                    "中小盘",
                    "策略",
                    "回顾",
                    "展望"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "中小盘"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "【建投中小盘】一周策略回顾与展望",
            "scores": {
                "News_content": "【建投中小盘】一周策略回顾与展望",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "益丰药房(603939.SH)实际控制人解除质押280万股",
            "features": {
                "keywords": [
                    "益丰药房",
                    "实际控制人",
                    "解除质押",
                    "280万股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "益丰药房(603939.SH)实际控制人解除质押280万股",
            "scores": {
                "News_content": "益丰药房(603939.SH)实际控制人解除质押280万股",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "“4+7”带量采购政策下的行业发展机遇",
            "features": {
                "keywords": [
                    "4+7",
                    "带量采购",
                    "政策",
                    "发展机遇"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "“4+7”带量采购政策下的行业发展机遇",
            "scores": {
                "News_content": "“4+7”带量采购政策下的行业发展机遇",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "益丰药房日均开出4家店，疯狂并购商誉暴增300%",
            "features": {
                "keywords": [
                    "益丰药房",
                    "日均开店",
                    "并购",
                    "商誉暴增",
                    "300%"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "益丰药房日均开出4家店，疯狂并购商誉暴增300%",
            "scores": {
                "News_content": "益丰药房日均开出4家店，疯狂并购商誉暴增300%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "2019年一季报首批社保基金持仓股曝光 7.51亿元布局8只潜力股",
            "features": {
                "keywords": [
                    "2019年一季报",
                    "社保基金",
                    "持仓股",
                    "7.51亿元",
                    "8只潜力股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "2019年一季报首批社保基金持仓股曝光 7.51亿元布局8只潜力股",
            "scores": {
                "News_content": "2019年一季报首批社保基金持仓股曝光 7.51亿元布局8只潜力股",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业2019年一季报前瞻:行业增速全年预期前低后高,加大配置中小市值标的",
            "features": {
                "keywords": [
                    "医药生物",
                    "2019年一季报",
                    "行业增速",
                    "前低后高",
                    "中小市值标的"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业2019年一季报前瞻:行业增速全年预期前低后高,加大配置中小市值标的",
            "scores": {
                "News_content": "医药生物行业2019年一季报前瞻:行业增速全年预期前低后高,加大配置中小市值标的",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]